Proposed LDT Rule Raises Many Questions but Provides Few Answers
FDA Law Blog
OCTOBER 6, 2023
The Proposed Rule states that Stage 4 and Stage 5 would not begin before October 1, 2027, and April 1, 2028, respectively, in order to enable laboratories to participate in negotiations preceding user fee reauthorization in 2027 (taking effect in FY2028, which begins on October 1, 2027).
Let's personalize your content